Results 201 to 210 of about 1,685,679 (247)

Genetic Mutations in Recurrent/Metastatic Papillary Thyroid Carcinoma

open access: yesThe Laryngoscope, EarlyView.
We investigated the mutational landscape and prognostic implications of recurrent/metastatic papillary thyroid carcinoma using nationwide C‐CAT data from 348 patients. CDKN2A, KMT2D, and concurrent TERT/BRAF mutations were independently associated with poorer overall survival, highlighting the potential prognostic value of comprehensive genomic ...
Hiromi Nagano   +3 more
wiley   +1 more source

Association Between an Oncogene and an Anti-Oncogene: The Adenovirus E1A Proteins Bind to the Retinoblastoma Gene Product

open access: yesNature, 1988
One of the cellular targets implicated in the process of transformation by the adenovirus E1A proteins is a 105K cellular protein. Previously, this protein had been shown to form stable protein/protein complexes with the E1A polypeptides but its identity
Stephen Friend   +2 more
exaly   +2 more sources

Oncogenic protein tyrosine kinases

Cellular and Molecular Life Sciences, 2004
Since it was first recognized, chronic myeloid leukemia (CML) has always represented a unique model to understand the molecular mechanisms underlying the onset and progression of a leukemic process. CML was the first recognized form of cancer to have a strong association with a recurrent chromosomal abnormality, the t(9;22) translocation, which ...
SAGLIO, Giuseppe, CILLONI, Daniela
  +8 more sources

G-Protein Oncogenes in Acromegaly

Hormone Research, 2008
G-proteins belong to a family of proteins which share the common properties of GTP binding and hydrolysis. Heterotrimeric G-proteins are composed of α-, β- and γ-subunits. The α-subunit which differs from one G-protein to another contains the GDP/GTP binding site and has intrinsic GTPase activity. The receptor occupancy causes displacement of bound GDP
A, Spada, L, Vallar
openaire   +2 more sources

Oncogenic proteins as tumor antigens

Current Opinion in Immunology, 1996
Human immune responses to oncogenic proteins have been reported and are continuing to be defined. Immunity to nonmutated overexpressed oncoproteins as well as to mutated or unique cancer-specific oncoproteins has been identified. Immune system based treatments targeting oncogenic proteins have shown therapeutic efficacy in animals models and are ...
M L, Disis, M A, Cheever
openaire   +2 more sources

The ras Oncogene Protein

1989
To date, over 40 discrete genes (oncogenes and proto-oncogenes) have been shown capable of inducing cellular transformation and tumor development (Bishop 1987). Only a few of these oncogenes have actually been shown to have a significant role in human cancer.
M. S. Marshall   +8 more
openaire   +1 more source

The Multilayered Regulation of the Oncogenic Protein YY1

Critical Reviews™ in Oncogenesis, 2017
The multifunctional protein Yin Yang 1 (YY1) plays critical roles in tumorigenesis. YY1 has been shown to be involved in the development, progression, resistance, and invasiveness of many types of cancers. Today, the value of YY1 as a prognostic marker and as a potential target in cancer therapy is being explored by multiple research groups around the ...
Raed, Rizkallah, Myra M, Hurt
openaire   +2 more sources

Serum Oncogene Proteins in Foundry Workers

Occupational Medicine, 1990
A new technique for detecting oncogene activation based on immunoblotting for oncogene proteins in serum has been applied to screen a cohort of foundry workers with well-defined workplace exposures to polycyclic aromatic hydrocarbon carcinogens. Three of the 18 individuals screened were found to have abnormal expression of the proteins of the ras and ...
P W, Brandt-Rauf   +6 more
openaire   +2 more sources

Oncogenic mechanisms of Evi-1 protein

Cancer Chemotherapy and Pharmacology, 2001
Although Evi-1 is thought to promote growth or block differentiation in some cell types, its biological functions have not been elucidated. To explore the mechanisms underlying Evi-1-induced oncogenesis, we investigated whether Evi-1 affects the signaling of transforming growth factor beta (TGF-beta), which inhibits proliferation of a wide range of ...
H, Hirai   +3 more
openaire   +2 more sources

G protein oncogenes in pituitary tumors

Trends in Endocrinology & Metabolism, 1992
G proteins are involved in the transduction of external signals from cell surface receptors to intracellular effectors. Somatic mutations activating the a-subunit of G(s) (the stimulatory regulatory protein of adenylyl cyclase) by inhibiting its intrinsic GTPase activity have been first identified in human GH-secreting adenomas and subsequently found ...
A, Spada, L, Vallar, G, Faglia
openaire   +2 more sources

Home - About - Disclaimer - Privacy